COSMECCA KOREA CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 37,350 KRW | +1.77% |
|
+5.81% | +2.89% |
| 2023 | Cosmecca Korea Co., Ltd.(KOSDAQ:A241710) added to S&P Global BMI Index | CI |
| 2023 | Cosmecca Korea Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 121,218 | 130,296 | 138,306 | 109,470 | 387,684 | 398,898 | - | - |
| Enterprise Value (EV) 2 | 207.1 | 215.7 | 230.6 | 109.5 | 387.7 | 431.7 | 400.4 | 368.4 |
| P/E ratio | 42.8 x | 49.8 x | 15.5 x | 41.2 x | 17.4 x | 12.7 x | 10.3 x | 8 x |
| Yield | 0.88% | - | - | - | - | - | - | - |
| Capitalization / Revenue | 0.35 x | 0.38 x | 0.35 x | 0.27 x | 0.82 x | 0.74 x | 0.65 x | 0.58 x |
| EV / Revenue | 0.6 x | 0.64 x | 0.58 x | 0.27 x | 0.82 x | 0.8 x | 0.65 x | 0.54 x |
| EV / EBITDA | 8.98 x | 9.16 x | 6.82 x | 4.04 x | 5.88 x | 5.35 x | 4.28 x | 3.32 x |
| EV / FCF | -19.6 x | -93.2 x | -211 x | - | - | 12.5 x | 10.9 x | 9.14 x |
| FCF Yield | -5.09% | -1.07% | -0.47% | - | - | 8.01% | 9.16% | 10.9% |
| Price to Book | 0.95 x | 1 x | 0.97 x | 0.75 x | - | 1.97 x | 1.65 x | 1.35 x |
| Nbr of stocks (in thousands) | 10,680 | 10,680 | 10,680 | 10,680 | 10,680 | 10,680 | - | - |
| Reference price 3 | 11,350 | 12,200 | 12,950 | 10,250 | 36,300 | 37,350 | 37,350 | 37,350 |
| Announcement Date | 2/27/20 | 3/18/21 | 2/23/22 | 2/23/23 | 2/23/24 | - | - | - |
1KRW in Million2KRW in Billions3KRW
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 347.1 | 339.1 | 396.5 | 399.4 | 470.7 | 541.2 | 614.3 | 682.3 |
| EBITDA 1 | 23.05 | 23.54 | 33.82 | 27.09 | 65.93 | 80.66 | 93.56 | 111 |
| EBIT 1 | 8.301 | 9.903 | 20.1 | 10.37 | 49.16 | 63.92 | 77.24 | 87 |
| Operating Margin | 2.39% | 2.92% | 5.07% | 2.6% | 10.44% | 11.81% | 12.57% | 12.75% |
| Earnings before Tax (EBT) 1 | 6.291 | 4.336 | 17.51 | 6.373 | 46.11 | 62.28 | 76.05 | 94.25 |
| Net income 1 | 2 | 2.622 | 8.912 | 2.656 | 22.07 | 31.45 | 38.88 | 49.85 |
| Net margin | 0.58% | 0.77% | 2.25% | 0.67% | 4.69% | 5.81% | 6.33% | 7.31% |
| EPS 2 | 265.0 | 245.0 | 834.0 | 249.0 | 2,090 | 2,935 | 3,635 | 4,668 |
| Free Cash Flow 3 | -10,547 | -2,314 | -1,091 | - | - | 34,600 | 36,675 | 40,300 |
| FCF margin | -3,039.1% | -682.53% | -275.22% | - | - | 6,393.79% | 5,970.02% | 5,906.49% |
| FCF Conversion (EBITDA) | - | - | - | - | - | 42,896.11% | 39,199.44% | 36,289.96% |
| FCF Conversion (Net income) | - | - | - | - | - | 110,015.9% | 94,340.84% | 80,842.53% |
| Dividend per Share | 100.0 | - | - | - | - | - | - | - |
| Announcement Date | 2/27/20 | 3/18/21 | 2/23/22 | 2/23/23 | 2/23/24 | - | - | - |
1KRW in Billions2KRW3KRW in Million
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 97.3 | 93.72 | 89 | 100.4 | 103.5 | 106.4 | - | 116.4 | 122.7 | 123.6 | 133 | 138.5 | 140.8 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBIT 1 | 6.56 | 1.39 | 0.612 | 3.061 | 2.936 | 3.758 | - | 13.7 | 15.04 | 14 | 15.45 | 16.78 | 18.52 |
| Operating Margin | 6.74% | 1.48% | 0.69% | 3.05% | 2.84% | 3.53% | - | 11.77% | 12.26% | 11.32% | 11.61% | 12.11% | 13.16% |
| Earnings before Tax (EBT) 1 | - | -0.0598 | 0.403 | - | - | -2.331 | - | - | 10.72 | 14.5 | 15.2 | 17.2 | 16 |
| Net income 1 | 3.161 | 1.265 | -0.023 | 1.719 | - | - | 5.914 | 7.276 | 4.405 | 7.9 | 8.8 | 8.95 | 7.85 |
| Net margin | 3.25% | 1.35% | -0.03% | 1.71% | - | - | - | 6.25% | 3.59% | 6.39% | 6.61% | 6.46% | 5.58% |
| EPS | - | - | - | - | - | - | 554.0 | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 11/5/21 | 2/23/22 | 5/6/22 | 8/5/22 | 11/4/22 | 2/23/23 | 8/14/23 | 11/6/23 | 2/23/24 | - | - | - | - |
1KRW in Billions
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | 85.9 | 85.4 | 92.3 | - | - | 32.8 | 1.48 | - |
| Net Cash position 1 | - | - | - | - | - | - | - | 30.5 |
| Leverage (Debt/EBITDA) | 3.725 x | 3.628 x | 2.73 x | - | - | 0.4066 x | 0.0158 x | - |
| Free Cash Flow 2 | -10,547 | -2,314 | -1,091 | - | - | 34,600 | 36,675 | 40,300 |
| ROE (net income / shareholders' equity) | 1.17% | 2.04% | 6.55% | 2.98% | - | 16.8% | 17.3% | 18.3% |
| ROA (Net income/ Total Assets) | 0.6% | 0.74% | 2.37% | 0.68% | - | 8.5% | 8.95% | 7.4% |
| Assets 1 | 332.2 | 354.9 | 375.6 | 392.2 | - | 370 | 434.4 | 673.6 |
| Book Value Per Share 3 | 11,958 | 12,150 | 13,319 | 13,732 | - | 18,967 | 22,690 | 27,761 |
| Cash Flow per Share 3 | 1,686 | - | 739.0 | - | - | 7,869 | 7,550 | 11,324 |
| Capex 1 | 28.6 | 14.2 | 8.98 | 11.6 | - | 12.1 | 17.3 | 15 |
| Capex / Sales | 8.23% | 4.2% | 2.26% | 2.9% | - | 2.24% | 2.81% | 2.2% |
| Announcement Date | 2/27/20 | 3/18/21 | 2/23/22 | 2/23/23 | 2/23/24 | - | - | - |
1KRW in Billions2KRW in Million3KRW
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
37,350
KRW
Average target price
56,500
KRW
Spread / Average Target
+51.27%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +2.89% | 294M | |
| -1.70% | 254B | |
| +12.81% | 19.89B | |
| 0.00% | 18.26B | |
| +0.38% | 11.16B | |
| -7.41% | 10.38B | |
| +16.34% | 7.63B | |
| +16.25% | 5.97B | |
| +2.25% | 4.65B | |
| -16.82% | 3.81B |
- Stock Market
- Equities
- A241710 Stock
- Financials Cosmecca Korea Co., Ltd.